Shell Asset Management’s Sangamo Therapeutics SGMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-42,138
| Closed | -$174K | – | 1403 |
|
|
2022
Q2 | $174K | Buy |
42,138
+73
| +0.2% | +$301 | 0.01% | 1154 |
|
|
2022
Q1 | $244K | Sell |
42,065
-6,230
| -13% | -$36.1K | 0.01% | 1117 |
|
|
2021
Q4 | $362K | Buy |
48,295
+12,655
| +36% | +$94.9K | 0.01% | 1039 |
|
|
2021
Q3 | $321K | Sell |
35,640
-1,530
| -4% | -$13.8K | 0.01% | 1061 |
|
|
2021
Q2 | $445K | Buy |
37,170
+2,010
| +6% | +$24.1K | 0.01% | 970 |
|
|
2021
Q1 | $441K | Buy |
+35,160
| New | +$441K | 0.01% | 910 |
|